Side-by-side financials for BCYC and NVS. Every figure below comes from audited SEC filings and refreshed market data.
| Metric | BCYC | NVS |
|---|---|---|
| Market cap | - | $293.12 B |
| US-listed rank | - | #47 |
| Revenue (latest FY) | $72.59M | - |
| Net income (latest FY) | -$218.96M | - |
| Net margin | -301.7% | - |
| SEC filings | 634 | 947 |
Full pages: BICYCLE THERAPEUTICS plc and Novartis AG, or browse the full rankings.